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Antimicrobial resistance was declared by the World Health Organization (WHO) in 2014 as the greatest threat 
for human and veterinary medicine.The development of resistance in E. coli may be due to haphazard use of 
antibiotics, plasmid-mediated genes,i.e. blaCTX-M, blaSHV, blaOXA. This work was aimed to detect the 
antibiotic resistant genes in multidrug-resistant extended-spectrum β-lactamase-producing E. coli from samples 
of children. 90 samples from chidren were collected. blaTEM, blaSHV, blaOXA, blaCTX-M and blaVEB 
resistance genes in drug-resistant E. coli were investigated. The blaTEM, blaSHV and blaCTX genes were 
detected in E.coli isolates. blaTEM genes were found to be in all isolates. The blaSHV gene was detected in 
14.28% of the isolates. The blaCTX-M gene was detected in 71.42% of the isolates blaOXA and blaVEB genes 
were not detected in any sample.The resistant genes sequences of the E.coli isolates from urine, blood, skin ande 
ndotracheal tube were deposited in the DDBJ/EMBL/GenBank nucleotide sequence databases.The resistance 
genes sequences of the Escherichia isolates are greatest closely associated to those of Escherichia coli. 
Keywords: E. coli; MDR; ESBLs; Children. 
1. Introduction  
Escherichia coli is the most common pathogens for most infections, particularly in developing countries, it 
caused a number of common bacterial infections including urinary tract infections, gastroenteritis and mainly 
neonatal meningitis, Also, E. coli is a major bacterial cause of Diarrhea which has been reported as leading 
cause of pediatric death worldwide. The Treatment of bacterial diarrhea and urinary tract infection has 
employed antibiotics [1,2].  
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1.1 Prevalence of multi-drug resistant E. coli 
The massive use of antibiotics, especially third generation cephalosporins, has been reported to be one of the 
factors contributing to the emergence and spread of bacterial resistance [3,4,5]. The spread of Infection with 
multidrug resistant bacteria is a global threat. Because it affects the treatment options for common infectious 
diseases, Nowadays, multidrug resistant bacteria are common in community-acquired infections as well and 
hospital-acquired infections [6]. the most common multidrug resistant organisms are Extended-spectrum beta-
lactamase (ESBL)-producing Enterobacteriaceae, ESBL is a type of beta-lactamases which are able to hydrolyze 
wide range of cephalosporins, beta-lactams and penicillins, ESBL enzymes have spread in part due to the 
transmission of mobile genetic elements between bacteria. The distribution of ESBL enzymes had led to 
outbreaks globally [7,8]. The prevalence of the ESBL genotypes varied by times and geographical regions. In 
several countries the Increase of drug-resistance incidence has been reported, most of the studies showed that 
the rates often doubling or more over 2 to 4 years. A British study reported that 5.2% of the isolates were ESBL 
producers, with an increased monthly incidence from 9.5 to 13.5 cases over a 2-year period [9]. Paediatric 
studies in the neonatal intensive care units reported the prevalence ranging from 4.3% to 75%.  Outside the 
neonatal age, ESBLs among hospitalised paediatric patients have recorded spread between 18.5% and 57.1%. 
but the carriage in community settings is lower, ranging from 0.1% to 12.4% [10]. A Study in Kathmandu 
reported the varying prevalence of ESBL bacteria, in Pokhara (27.7%), in Kathmandu (11 18%), in pediatric 
hospital in Kathmandu (14 43%) [11]. In France, ESBL implicated in urinary tract infections in the paediatric 
population were stable in term of prevalence (around 5%) and species distribution (90% E. coli) [12].  In Bolivia 
and Peru several studies showed a steady rise from 0.1% in 2002 to 12.4% in 2011 [13,14,15]. However, in 
Senegal ESBL-producing E. coli carriage reported among children in a very remote community, where prior 
antibiotic use was most unlikely, which suggest that other factors may play a role in promoting colonization 
[16]. This highlights the significant need for improved control practices and infection prevention and to prevent 
the rapid distribution of ESBL producing E. coli. 
1.2 Genes responsible of resistance 
Identification and characterization of ESBL producing E. coli in routine treatment of infectious diseases in 
pediatric patients can be particularly useful in reducing inappropriate and unnecessary antimicrobial use. ESBLs 
might include Class A, C or D enzymes that are mostly inhibited by clavulanic acid, the common spread 
mechanism is by horizontal gene transfer [5]. Class A enzymes including TEM, SHV, and CTX-M, and Class D 
enzyme OXA are generally found among Enterobacteriaceae [17]. The ESBLs types of TEM and SHV were 
detected in Europe and the United States between1980-1990 [19,20], but CTX-M was spread in Asian countries 
[21,22]. During last decades, CTX-M14 and CTX-M15 were spread globally in humans and animals [23]. The 
recent studies reported that the cefotaxime-hydrolyzing beta-lactamase, (CTX-M) enzyme now predominates 
because of superior transmission efficiency [19]. ESBLs generality can be classified into three major groups: 
TEM, SHV and CTX-M. Worldwide, ESBL-producing bacteria are most frequently found among the members of 
the family Enterobacteriaceae, especially E. coli. Now, there are more than 60 different variants of CTX-M-type 
ESBLs, which further classified based on their amino acid sequences into five different subgroups: CTX-M-1, 
CTX-M-2, CTX-M-8, CTX-M-9 and CTX-M-25 groups. Of these, CTX-M-1, CTX-M-2 and CTX-M-9 groups are 




the most common [24]. However, in the initial of 2000s, the dominant CTX-M group shifted from CTX-M-2 to 
CTX-M-9 The β -lactamases production is an important system of resistance to b-lactam antibiotics among 
gram-negative bacteria. Expanded-spectrum cephalosporins have been prepared to resist degradation by the 
older broad-spectrum b-lactamases like TEM-1, TEM-2, and SHV-1. The reaction to the expanded-spectrum 
cephalosporins amongst the members of the Enterobacteriaceae family requiring inducible b-lactamases has 
been the production of mutant forms of the older b-lactamases called extended-spectrum b-lactamases (ESBL). 
The enzymes are able of hydrolysing the newer cephalosporins and aztreonam. Studies by biochemical and 
molecular techniques show that many ESBLs are derivatives of older TEM-1, TEM-2, or SHV-1 b-lactamases, 
some of which differ from the parent enzyme by only one or two amino acids [25]. Several types of ESBLs have 
been found in many countries. The TEM and SHV types were first found in Western Europe. The VEB was first 
reported in a single isolate of E. coli in Vietnam [26]. only few studies described the prevalence and the 
distribution of extended spectrum beta-lactamase producing E. coli, so the detection of the resistance genes was 
an important need, especially among children because the wide range of serious diseases which caused by ESBL 
producing E. coli. Therefore, this study was aimed to detect the resistant genes of multidrug-resistant ESBL-
producing E. coli isolated from children's samples. 
2. Materials and Methods 
2.1 Collection of samples  
A total of 90 samples (from Children) were collected from patients. The samples were collected by the staffs of 
Microbiology Labs of hospitals. The collected samples were included 76 samples from urine, 4 samples from 
skin, 5 samples from endotracheal tube and 5 samples from blood.   
2.2 Isolation and identification of E. coli  
The swabs collected were streaked on MacConkey Agar plates. The plates were incubated for 24-48 hours at 
37
o
C. The suspected E. coli showed red colonies. Morphological and biochemical characteristics of bacterial 
isolates were determined after incubation at 37ºC for 24h. The bacterial isolates were characterized according to 
Bergey’s Manual of Systematic Bacteriology [27].  
2.3 Isolation of chromosomal DNA  
The samples were cultured on Nutrient Agar. Thermo Scientific GeneJET Genomic DNA Purification Kit was 
used according to the manufacture. 
2.4 Detection of resistance genes by polymerase chain reaction (PCR) 
The presence of genes associated with resistance β-lactams (Amoxicillin-clavulante, Piperacillin-Tazobactam) 
(blaTEM, blaSHV, blaOXA, blaVEB, blaCTX-M) were detected by PCR. The primers (Table 1) were planned by 
Primer-BLAST web site [28]. GoTaq Green Master Mix kit (Promega, USA) was used. PCR reactions were 
achieved according to Abo-Amer and his colleagues (2018) [29]. Amplification reactions were carried out using 




a DNA thermocycler (Labnet International, Model: MultigeneOpti Max). PCR products were investigated by 
agarose (0.7%) gel electrophoresis. The PCR products of resistance genes were sequenced (Macrogen). 
Tables 
Table 1: The primer sequences and predicted sizes used in the PCR 
Target gene Encoding  Oligonucleotide sequence (5′-3′)  Size  
(bp) 




















β-lactamase   
 
F:5′- CCCCTCAAGACCTTTTGCCT-3′ 
R:5′- TTCAACCCGCCATTGCCTAT -3′ 
 
657 
3. Results  
3.1 Isolation and identification of E. coli 
Nighty bacterial isolates were recovered from different sources of children. Bacterial isolates were recovered 
from children such as urine, skin, blood and endotracheal tube. According to Berge’s Manual of Systematic 
Bacteriology, 90 bacterial isolates were described as E. coli. E. coli isolates were selected for antimicrobial 
susceptibility assay.  
3.2 Antimicrobial resistance genes from Children isolates  
Genes responsible for antimicrobial resistance were investigated in seven MDR E. coli isolates (resistant to 9 or 
more antimicrobial agents) isolates URCH05, URCH61, URCH58, URCH76, URCH70, ETCH69, SSCH63. 
Initially, the chromosomal DNA was isolated from these isolates. A volume of 5μl of each preparation was 
resolved by 0.7% agarose gel electrophoresis, confirming the presence of sufficing DNA for PCR reactions. The 
presence of genes (blaTEM, blaSHV, blaOXa, blaCTX-M and blaVEB) responsible for resistance to extended 
spectrum beta lactam antibiotics (ESBLs) mediate resistance to all penicillins, third generation cephalosporins 




(ceftazidime, cefotaxime, and ceftriaxone) and aztreonam (except cephamycins or carbapenems); by PCR.  
These genes were PCR amplified of the isolates URCH05, URCH61, URCH58, URCH76, URCH70, ETCH69 
and SSCH63. A volume of 5 μl of each PCR reaction was analyzed by 1% agarose gel electrophoresis which 
confirmed the PCR-products were of the expected sizes. The presence of the gene blaTEM was detected in all of 
the isolates (URCH05, URCH61, URCH58, URCH76, URCH70, ETCH69 and SSCH63), The gene blaSHV 
was detected in one isolate (URCH70). The gene blaCTX-M was detected five isolates (URCH05, URCH61, 
URCH58, URCH76 and SSCH63). The genes blaOXA and blaVEB were not detected in any isolate they may be 
present in plasmid not in chromosomal DNA (Table 2). 




blaVEB blaCTX-M blaOXA blaSHV blaTEM 
- + - - + CEF, CXM, CTX, CRO, 
FEP, ATM, AMP, 
AMC, SXT, CTP, LVX 
SSCH63 
- - - - + GN, CEF, CXM, CTX, 
CRO, FEP, ATM, AMP, 
AMC, SXT, CTP, LVX 
ETTCH69 
- + - - + GM, CEF, CXM, CTX, 
CRO, FEP, ATM, AMP, 
AMC. 
URCH05 
- + - - + EMP, CEF, CXM, CTX, 
CRO, FEP, ATM, AMP, 
AMC 
URCH61 
- + - - + GN, EMP, CEF, CXM, 
CTX, CRO, FEP, ATM, 
AMP, AMC, SXT, CTP, 
LVX. 
URCH58 
- + - - + CEF, CXM, CTX, CRO, 
FEP, ATM, AMP, 
AMC, SXT 
URCH76 
- - - + + CEF, CXM, CTX, CRO, 
FEP, ATM, AMP, 
AMC, SXT. 
URCH70 
The resistant genes sequences of the E. coli isolates from urine, skin, blood and endotracheal tube, were 
deposited in the DDBJ/EMBL/GenBank nucleotide sequence databases with the accession numbers:  
blaCTX-M8SSCH63 (LC431660), blaCTX-M9URCH05 (LC431661), blaCTX-M10URCH61  
(LC431662), blaCTX-M11URCH58(LC431663), blaCTX-M12URCH76(LC431664), 
blaTEM8SSCH63(LC431643), blaTEM9ETTCH69(LC431644), blaTEM10URCH05(LC431645) 
, blaTEM11URCH61(LC431646), blaTEM12URCH58(LC431647), blaTEM13URCH76(LC431648), 
blaTEM14URCH70(LC431649), blaSHV3URCH70(LC431652). 
The nucleotide sequences of MDR bacterial isolates were compared to existing sequences in the databases. A 




Klebsiella pneumoniae TEM-4 H67 pRYC11 (NG_050265) 
Klebsiella pneumoniae TEM-197 FSP 286/05 (NG_050232) 
Escherichia coli blaTEM-116 allele strain KIB22 ( KY466964) 
Escherichia coli blaTEM-116 allele strain KRB20 (KY466965) 
Escherichia coli blaTEM-116 allele  strain KSR10 (KY466967) 
Escherichia coli blaTEM-116 allele strain KMT25 (KY466966) 





















Salmonella enterica blaTEM strain AS 063 ( JN990824) 
dendrogram demonstrating the results of resistant genes analysis is shown in Figures 1,2,3 As demonstrated. 
Figure 1A: phylogenetic tree of multidrug-resistant bacterial isolates based on the resistant gene (blaTEM) was 
constructed by neighbor-joining method. The scale bar shows the genetic distance. The number presented next 
to each node shows the percentage bootstrap value of 1000 replicates. The Salmonella entericawas treated as the 
out-group. The GenBank accession numbers of the bacteria are presented in parenthes. 




Salmonella typhimurium blaSHV2 gene (L47119 
Klebsiella pneumoniae SHV-48 (NG_050085) 
Klebsiella pneumoniae SHV-110 gene (NG_050001) 
Klebsiella pneumoniae SHV-9 (NG_050125) 
Escherichia coli blaSHV strain 
WCHEC96200(CP022229) 
Escherichia coli blaSHV strain AR_0114 
(CP021732) 
Escherichia coli blaSHV strain 
5CRE51(CP021175) 
72
 blaSHV3URCH70  
 

























Figure 2A: phylogenetic tree of multidrug-resistant bacterial isolates based on the resistant gene (blaSHV) was 
constructed by neighbor-joining method. The scale bar shows the genetic distance. The number presented next 
to each node shows the percentage bootstrap value of 1000 replicates. The Salmonella entericawas treated as the 
























Figure 3A: phylogenetic tree of multidrug-resistant bacterial isolates based on the resistant gene (blaCXT-M) 
was constructed by neighbor-joining method. The scale bar shows the genetic distance. The number presented 
next to each node shows the percentage bootstrap value of 1000 replicates. The Salmonella entericawas treated 
as the out-group. The GenBank accession numbers of the bacteria are presented in parentheses 
The resistant genes sequences of the Escherichia isolates are greatest closely associated to Escherichia coli.  
The blaTEM gene of isolates URCH05, URCH61, URCH58, URCH76, URCH70, ETCH69 and SSCH63. 
shares 99% similarity with that of Escherichia coli blaTEM-116 allele strains (KIB22, KWB6, KSR10, KMT25, 
KRB20). These results suggest that the isolates (URCH05, URCH61, URCH58, URCH76, URCH70, ETCH69 
and SSCH63) are new isolates of the Escherichia coli. The blaSHV gene of isolate URCH70 shares 99% 
similarity with that of Escherichia coli blaSHV strain Z1002. These results suggest that the isolate (URCH70) 
Salmonella enterica CTX-M-151 strain TUM12370 (NG_048937) 
Klebsiella pneumoniae CTX-M-2 strain 011392316 (NG_055502) 
Klebsiella pneumoniae CTX-M-62 pJIE137 (NG_049013) 







Escherichia coli strain ER286 (blaCTX-M-3) gene (KP698221.1) 
Escherichia coli blaCTX-M-3 strain B-1205/15 (KX179569) 
Escherichia coli blaCTX-M-3a strain 201501610 ( KT427392) 
556 
390 







 blaCTX-M9URCH05  
959 
0.05 
Escherichia coli blaCTX gene  strain SKGH_28(KY792786) 




are new isolates of the Escherichia coli. The blaCTX-M gene of isolates URCH05, URCH61, URCH58, 
URCH76 and SSCH63.  shares 99% similarity with that of Escherichia coli blaCTX-M gene strains Escherichia 
coli ER286 strain. these results suggest that the isolates (URCH05, URCH61, URCH58, URCH76 and SSCH63) 
are new isolates of the Escherichia coli. These results are compatible with the conclusions of the morphological 
and biochemical characterization.  
4. Discussion 
Molecular analysis of ESBL resistant isolates indicated the presence of at least three genes that encode 
resistance. We observed a positive correlation between phenotypic and genotypic profiles (SHV, TEM and CTX-
M) among our isolates, in our study, we observed diverse genotypes of ESBL among E coli isolates, the high 
spread of antimicrobial resistance and increased prevalence of ESBL-producing E. coli is the major findings of 
this study. A high prevalence of ESBL was found among pediatric patients. Identification and detection of 
ESBL producers in routine treatment of infectious diseases in pediatric patients can reduce unnecessary and 
inappropriate antimicrobial use [30]. In the present study, blaCTX-M gene was detected in (71.42%) among E. 
coli isolates, several studies showed that the most common resistance conferring gene was blaCTX-M among E. 
coli isolates obtained from children, in Canadian study from 2012 to 2017, the patients age were under 18 years, 
ESBL isolates showed predominance of blaCTX-M-15 (62%) and blaCTX-M-27 (16%) genes [31], Also, At a 
paediatric hospital in South Africa, found in 55.9% of E. coli isolates were ESBL [32].  At A Japanese children's 
hospital, A study Among 242 of E. coli isolates, 215 isolates (88.8%) were blaCTX-M positive [33]. In Nepal, 
blaCTX-M (66.1%) were common ESBL genotypes [34], in Iran, blaCTX-M9 was the most common (68.2%) 
among isolates [35], In Qatar: all isolates harbored blaCTX-M gene (100%) [36]. A Nigerian study reported that 
42.86% of E. coli isolates are blaCTX-M positive [37]. In this study, blaTEM (100%) was the most predominant 
genotype of ESBL among E coli isolates, blaSHV gene was detected in (14.28%), Similar to our study, in Nepal, 
Among MDR E. coli isolates showed that 40.3% from E. coli isolates were producing extended-spectrum β-
lactamases (ESBL). blaTEM (83.8%), blaSHV (4.8%) [34], In Addition, in Tahran A study reported that 90.9% 
of the E. coli which were Isolated from Patients with Diarrhea carried at least 1 ESBL encoding gene, blaTEM 
(54.5%) and blaSHV (45.4%) [35], at Nigerian paediatric hospital a study showed that the prevalence of ESBL 
resistance genes were: 50.00% blaTEM and 7.14% blaSHV [37]. In Qatar, Molecular analysis of resistant 
isolates to third generation cehalosporins indicated the presence of at least two genes that encode resistance. the 
study reported the positive correlation between phenotypic and genotypic profiles (CTX-M, SHV and TEM) in 
all the isolates [36]. Finally, in this study blaOXA and blaVEB were not detected in any sample, but in a study in 
Iran, blaVEB was detected in (5%) of the isolates, also in other Iranian study blaOXA was detected in (40.9%) of 
isolates [38]. In this study, the prevalence of resistant genes in ESBL- producing E. coli isolates in children were 
higher than some other investigation. The blaTEM, blaSHV, blaCTX-M genes which were detected in our 
isolates shares 99% similarity with Escherichia coli blaTEM-116 allele strains, Escherichia coli blaSHV strain 
Z1002, Escherichia coli ER286 strain, these results suggest that the isolates are new isolates of the Escherichia 
coli. 
 





This proposal represents the incidence of multidrug-resistant extended-spectrum β-lactamase-producing E. coli 
among children. E. coli isolates positive for ESBLs phenotypically will be tested by PCR technique for ESBLs 
genes in this study. blaTEM, blaSHV and blaCTX genes were detected in E. coli isolates, blaTEM (100%), 
blaSHV (14.28%) and blaCTX (71.42%) in children. 
6. Limitations 
This study had a number of limitations. This study focused on children only, So it was difficult to obtain and 
collect the used isolates, since we were unable to trace the history of antibiotic prescriptions for the patients, the 
association between antibiotic prescription and the genotype of ESBL was unclear. also, this study was cross-
sectional, we were unable to analyze the risk factors of the patients. 
7. Recommendations 
Our study will be a useful and helpful reference for future studies to explore and expand on the prevalence of 
ESBL producing E. coli in both children and adults in clinical and nonclinical settings, this study should cover 
all the hospitals in all the country to determine ESBL prevalence, in addition, Knowledge of the antimicrobial 
resistance patterns and resistance genes of ESBL producing E. coli pathogens is useful for surveillance and 
control of antibiotic resistance. Further research into multidrug resistance E. coli especially ESBL in children is 
essential in middle east. 
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